postoperative administration of radioiodine

Abstract

BACKGROUND

In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy, the postoperative administration of radioiodine (iodine-131) is controversial in the absence of demonstrated benefits.

https://www.nejm.org/doi/10.1056/NEJMoa2111953